Retinitis Pigmentosa Clinical Trials in Baltimore, MD

View the best 10 retinitis pigmentosa medical studies in Baltimore, Maryland. Access promising new therapies by applying to a Baltimore-based Retinitis Pigmentosa clinical trial.

Trials in Baltimore, Maryland

Here are the top 6 medical studies for retinitis pigmentosa in Baltimore, Maryland

NAC effervescent tablets

Antioxidant

Recruiting2 awardsPhase 1

This trial is testing N-acetylcysteine (NAC) tablets to help people with Retinitis Pigmentosa (RP), a disease that causes vision loss. NAC is an antioxidant that protects eye cells from damage. The goal is to see if NAC can slow down or stop the progression of vision loss in RP patients.

N-acetylcysteine

Antioxidant

Recruiting1 awardPhase 3

This trial is testing if N-acetylcysteine (NAC) can help slow down vision loss in people with Retinitis Pigmentosa (RP). RP is a genetic condition that causes gradual vision loss. NAC reduces damage caused by too much oxygen around eye cells, potentially protecting vision. N-acetylcysteine (NAC) has been shown to reduce oxidative damage and increase cone function/survival in studies related to RP.

Metformin hydrochloride

Biguanide

Recruiting1 awardPhase 1 & 2

This trial is testing whether the drug metformin can help people with ABCA4 retinopathy, a disease which causes waste material to build up in the eye and can lead to vision loss.

EDIT-101

Gene Therapy

Recruiting1 awardPhase 1 & 2

This trial is testing a new gene therapy for people with a specific genetic mutation that causes Leber Congenital Amaurosis, a severe form of vision loss.

AGTC-501

Virus Therapy

Recruiting1 awardPhase 2 & 3

This trial will test two different doses of a gene therapy called AGTC-501 to see how safe and effective it is in treating a certain type of eye disease in men.

OCU400

Gene Therapy

Recruiting1 awardPhase 1 & 2

This trial tests OCU400, an eye injection, in patients with specific genetic mutations causing RP and LCA. The treatment aims to correct faulty genes to prevent vision loss.

Popular Filters

Trials With No Placebo

Gene Therapy

OCU400 for Retinitis Pigmentosa

Recruiting1 awardPhase 1 & 2

Philadelphia, Pennsylvania

This trial tests OCU400, an eye injection, in patients with specific genetic mutations causing RP and LCA. The treatment aims to correct faulty genes to prevent vision loss.

Virus Therapy

AGTC-501 for Retinitis Pigmentosa

Recruiting1 awardPhase 2 & 3

Philadelphia, Pennsylvania

This trial will test two different doses of a gene therapy called AGTC-501 to see how safe and effective it is in treating a certain type of eye disease in men.

Biguanide

Oral Metformin for Stargardt Disease

Recruiting1 awardPhase 1 & 2

Bethesda, Maryland

This trial is testing whether the drug metformin can help people with ABCA4 retinopathy, a disease which causes waste material to build up in the eye and can lead to vision loss.

VR Assessment for Retinal Disease

Recruiting1 awardPhase 1

Bethesda, Maryland

This trial is testing a virtual reality tool to see if it can help assess mobility in people with retinal disease. Eligible participants are those aged 5 and older with retinal disease that affects their vision, and healthy volunteers. The VR tool will be used to navigate through 4 obstacle courses presented in VR.

Antioxidant

N-acetylcysteine for Retinitis Pigmentosa

Recruiting2 awardsPhase 1

Baltimore, Maryland

This trial is testing N-acetylcysteine (NAC) tablets to help people with Retinitis Pigmentosa (RP), a disease that causes vision loss. NAC is an antioxidant that protects eye cells from damage. The goal is to see if NAC can slow down or stop the progression of vision loss in RP patients.

Gene Therapy

Gene Therapy for Leber Congenital Amaurosis

Recruiting1 awardPhase 1 & 2

Philadelphia, Pennsylvania

This trial is testing a new gene therapy for people with a specific genetic mutation that causes Leber Congenital Amaurosis, a severe form of vision loss.

Frequently Asked Questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

Is there any support for travel costs?

Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.

Will I know what medication I am taking?

This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.

How long do clinical trials last?

Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.

Do you verify all the trials on your website?

All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.

How quickly will I hear back from a clinical trial?

Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.